109
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

mTOR inhibition and adult T-cell leukemia

, , , &
Pages 645-647 | Received 03 Sep 2008, Accepted 21 Dec 2008, Published online: 01 Jul 2009

References

  • Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50: 481–492
  • Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476–6480
  • Shimoyama M. Treatment of patients with adult T-cell leukemia-lymphoma: an overview. Advances in Adult T-Cell Leukemia and HTLV-1 Research, K Takatsuki, Y Hinuma, M Yoshida. Scientific Societies Press, Tokyo, Japan 1992; 39: 43–56
  • Wullschleger S, Loewith R, Hall M N. TOR signaling in growth and metabolism. Cell 2006; 124: 471–484
  • Majumber P K, Febbo P G, Bikoff R, Berger R, Xue Q, Sellers W R, et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004; 10: 594–601
  • Gingras A C, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001; 15: 807–826
  • Burchert A, Wang Y, Cai D, von Bubnoff N, Paschka P, Neubauer A, et al. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development. Leukemia 2005; 19: 1774–1782
  • Huang S, Houghton P J. Targeting mTOR signaling for cancer therapy [review]. Curr Opin Pharmacol 2003; 3: 371–377
  • Hirase C, Maeda Y, Takai S, Kanamaru A. Hypersensitivity of Ph-positive lymphoid cell lines to rapamycin; possible clinical application of mTOR inhibitor. Leukemia Res 2009; 33: 450–459
  • Ikezoe T, Nishioka C, Bandobashi K, Yang Y, Kuwayama Y, Taguchi H, et al. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leukemia Res 2007; 31: 673–682
  • Berridge M V, Tan A S. Characterization of the cellular reduction of 3-(4, 5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993; 303: 474–482

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.